sterna biologicals announces publication of pre-clinical data in Gastroenterology
Marburg, Germany, 10 October 2016
- Paper summarizing role of GATA-3 in ulcerative colitis published in Gastroenterology
- SECURE study of SB012 in patients with moderate to severe ulcerative colitis continues to progress (NCT02129439)
sterna biologicals GmbH & Co. KG ("sterna biologicals") announced today that detailed mechanistic investigations of the role of GATA-3 in ulcerative colitis, performed primarily by Prof Markus Neurath's group in Erlangen (Germany), were published in Gastroenterlogy (Popp et al, 2016).